Erratum: Anti-type II collagen antibody accelerates arthritis via CXCR2-expressing cells in IL-1 receptor antagonist-deficient mice (European Journal of Immunology (2007) vol. 37 (10) 10.1002/eji.200737313);Anti-type II collagen antibody accelerates arthritis via CXCR2-expressing cells in IL-1 receptor antagonist-deficient mice

European Journal of Immunology

Volumn 37, Issue 10, 2007, Pages 2753-2763

  Kagari, Takashi ^a   Tanaka, Daisuke ^a   Doi, Hiromi ^a   Iwakura, Yoichiro ^b   Shimozato, Takaichi ^a  

^a DAIICHI SANKYO CO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Animal models; CXCR2; Neutrophils; Rheumatoid arthritis

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CXCR2; CHEMOTACTIC FACTOR; COLLAGEN ANTIBODY; COLLAGEN TYPE 2; CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; LIGAND;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELL MIGRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE SEVERITY; FLOW CYTOMETRY; HISTOPATHOLOGY; MALE; MOUSE; NEUTROPHIL; NEUTROPHIL COUNT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS;

EID: 35348848467     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200737313     Document Type: Erratum

References (40)

1. Lee, D. M. and Weinblatt, M. E., Rheumatoid arthritis. Lancet 2001. 358: 903-911.
2. Courtenay, J. S., Dallman, M. J., Dayan, A. D., Martin, A. and Mosedale, B., Immunisation against heterologous type II collagen induces arthritis in mice. Nature 1980. 283: 666-668.
3. Andriopoulos, N. A., Mestecky, J., Miller, E. J. and Bradley, E. L., Antibodies to native and denatured collagens in sera of patients with rheumatoid arthritis. Arthritis Rheum. 1976. 19: 613-617.
4. Monach, P. A., Benoist, C. and Mathis, D., The role of antibodies in mouse models of rheumatoid arthritis, and relevance to human disease. Adv. Immunol. 2004. 82: 217-248.
5. Terato, K., Hasty, K. A., Reife, R. A., Cremer, M. A., Kang, A. H. and Stuart, J. M., Induction of arthritis with monoclonal antibodies to collagen. J. Immunol. 1992. 148: 2103-2108.
6. Terato, K., Harper, D. S., Griffiths, M. M., Hasty, D. L., Ye, X. J., Cremer, M. A. and Seyer, J. M., Collagen-induced arthritis in mice: synergistic effect of E. coli lipopolysaccharide bypasses epitope specificity in the induction of arthritis with monoclonal antibodies to type II collagen. Autoimmunity 1995. 22: 137-145.
7. Kagari, T., Doi, H. and Shimozato, T., The importance of IL-1beta and TNF-alpha, and the noninvolvement of IL-6, in the development of monoclonal antibody-induced arthritis. J. Immunol. 2002. 169: 1459-1466.
8. Kagari, T., Tanaka, D., Doi, H. and Shimozato, T., Essential role of Fc gamma receptors in anti-type II collagen antibody-induced arthritis. J. Immunol. 2003. 170: 4318-4324.
9. Dinarello, C. A., Interleukin-1 and interleukin-1 antagonism. Blood 1991. 77: 1627-1652.
10. Bankers-Fulbright, J. L., Kalli, K. R. and McKean, D. J., Interleukin-1 signal transduction. Life Sci. 1996. 59: 61-83.
11. Choy, E. H. and Panayi, G. S., Cytokine pathways and joint inflammation in rheumatoid arthritis. N. Engl. J. Med. 2001. 344: 907-916.
12. Eisenberg, S. P., Evans, R. J., Arend, W. P., Verderber, E., Brewer, M. T., Hannum, C. H. and Thompson, R. C., Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature 1990. 343: 341-346.
13. Iwakura, Y., Roles of IL-1 in the development of rheumatoid arthritis: Consideration from mouse modes. Cytokine Growth Factor Rev. 2002. 13: 341-355.
14. Cohen, S., Hurd, E., Cush, J., Schiff, M., Weinblatt, M. E., Moreland, L. W., Kremer, J. et al., Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: Results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2002. 46: 614-624.
15. Gabay, C., Marinova-Mutafchieva, L., Williams, R. O., Gigley, J. P., Butler, D. M., Feldmann, M. and Arend, W. P., Increased production of intracellular interleukin-1 receptor antagonist type I in the synovium of mice with collagen-induced arthritis: A possible role in the resolution of arthritis. Arthritis Rheum. 2001. 44: 451-462.
16. Palmer, G.., Talabot-Ayer, D., Szalay-Quinodoz, L., Maret, M., Arend, W. P. and Gabay, C., Mice transgenic for intracellular interleukin-1 receptor antagonist type 1 are protected from collagen-induced arthritis. Eur. J. Immunol. 2003. 33: 434-440.
17. Horai, R., Saijo, S., Tanioka, H., Nakae, S., Sudo, K., Okahara, A., Ikuse, T. et al., Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice. J. Exp. Med. 2000. 191: 313-320.
18. Horai, R., Nakajima, A., Habiro, K., Kotani, M., Nakae, S., Matsuki, T., Nambu, A. et al., TNF-alpha is crucial for the development of autoimmune arthritis in IL- 1 receptor antagonist-deficient mice. J. Clin. Invest. 2004. 114: 1603-1611.
19. Nakae, S., Saijo, S., Horai, R., Sudo, K., Mori, S. and Iwakura, Y., IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist. Proc. Natl. Acad. Sci. USA 2003. 100: 5986-5990.
20. Nandakumar, K. S., Svensson, L. and Holmdahl R., Collagen type II-specific monoclonal antibody-induced arthritis in mice: Description of the disease and the influence of age, sex, and genes. Am. J. Pathol. 2003. 163: 1827-1837.
21. Tanaka, D., Kagari, T., Doi, H. and Shimozato, T., Essential role of neutrophils in anti-type II collagen antibody and lipopolysaccharide-induced arthritis. Immunology 2006. 119: 195-202.
22. Snyderman, R. and Pike, M. C., Chemoattractant receptors on phagocytic cells. Annu. Rev. Immunol. 1984. 2: 257-281.
23. Lee, J., Cacalano, G., Camerato, T., Toy, K., Moore, M.W. and Wood, W. I., Chemokine binding and activities mediated by the mouse IL-8 receptor. J. Immunol. 1995. 155: 2158-2164.
24. Bozic, C. R., Kolakowski, L. F. Jr., Gerard, N. P., Garcia-Rodriguez, C., von Uexkull-Guldenband, C., Conklyn, M. J., Breslow, R. et al., Expression and biologic characterization of the murine chemokine KC. J. Immunol. 1995. 154: 6048-6057.
25. Ottonello, L., Cutolo, M., Frumento, G., Arduino, N., Bertolotto, M., Mancini, M., Sottofattori, E. and Dallegri, F., Synovial fluid from patients with rheumatoid arthritis inhibits neutrophil apoptosis: Role of adenosine and proinflammatory cytokines. Rheumatology 2002. 41: 1249-1260.
26. Simon, H. U., Neutrophil apoptosis pathways and their modifications in inflammation. Immunol. Rev. 2003. 193: 101-110.
27. Hall, D. J., Brownlee, C. and Stiles, C. D., Interleukin-1 is a potent regulator of JE and KC gene expression in quiescent BALB/c fibroblasts. J. Cell. Physiol. 1989. 141: 154-159.
28. Huang, S., Paulauskis, J. D. and Kobzik, L., Rat KC cDNA cloning and mRNA expression in lung macrophages and fibroblasts. Biochem. Biophys. Res. Commun. 1992. 184: 922-929.
29. Feng, L., Xia, Y., Kreisberg, J. I. and Wilson, C. B., Interleukin-1 alpha stimulates KC synthesis in rat mesangial cells: glucocorticoids inhibit KC induction by IL-1. Am. J. Physiol. 1994. 266: 713-722.
30. Tebo, J. M., Datta, S., Kishore, R., Kolosov, M., Major, J. A., Ohmori, Y. and Hamilton, T. A., Interleukin-1-mediated stabilization of mouse KC mRNA depends on sequences in both 5′ and 3′-untranslated regions. J. Biol. Chem. 2000. 275: 12987-12993.
31. Pillinger, M. H. and Abramson, S. B., The neutrophil in rheumatoid arthritis. Rheum. Dis. Clin. North. Am. 1995. 21: 691-714.
32. Chuntharapai, A., Lee, J., Hébert, C. A. and Kim, K. J., Monoclonal antibodies detect different distribution patterns of IL-8 receptor A and IL-8 receptor B on human peripheral blood leukocytes. J. Immunol. 1994. 153: 5682-5688.
33. Petering, H., Götze, O., Kimmig, D., Smolarski, R., Kapp, A. and Elsner, J., The biologic role of interleukin-8: Functional analysis and expression of CXCR1 and CXCR2 on human eosinophils. Blood 1999. 93: 694-702.
34. Van den Steen, P. E., Proost, P., Grillet, B., Brand, D. D., Kang, A. H., Van Damme, J. and Opdenakker, G., Cleavage of denatured natural collagen type II by neutrophil gelatinase B reveals enzyme specificity, post-translational modifications in the substrate, and the formation of remnant epitopes in rheumatoid arthritis. FASEB J. 2002. 16: 379-389.
35. Itoh, T., Matsuda, H., Tanioka, M., Kuwabara, K., Itohara, S. and Suzuki, R., The role of matrix metalloproteinase-2 and matrix metalloproteinase-9 in antibody-induced arthritis. J Immunol. 2002. 169: 2643-2647.
36. Merz, D., Liu, R., Johnson, K. and Terkeltaub, R., IL-8/CXCL8 and growth-related oncogene alpha/CXCL1 induce chondrocyte hypertrophic differentiation. J. Immunol. 2003. 171: 4406-4415.
37. Borzi, R. M., Mazzetti, I., Marcu, K. B. and Facchini, A., Chemokines in cartilage degradation. Clin. Orthop. Relat. Res. 2004. 427 (Suppl): S53-61.
38. Brown, C. R., Blaho, V. A. and Loiacono, C. M., Susceptibility to experimental Lyme arthritis correlates with KC and monocyte chemoattractant protein-1 production in joints and requires neutrophil recruitment via CXCR2. J. Immunol. 2003. 171: 893-901.
39. Belperio, J. A., Keane, M. P., Burdick, M. D., Londhe, V., Xue, Y. Y., Li, K., Phillips, R. J. and Strieter, R. M., Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced lung injury. J. Clin. Invest. 2002. 110: 1703-1716.
40. Tumpey, T. M., Fenton, R., Molesworth-Kenyon, S., Oakes, J. E. and Lausch, R. N., Role for macrophage inflammatory protein 2 (MIP-2), MIP-1alpha, and interleukin-1alpha in the delayed-type hypersensitivity response to viral antigen. J. Virol. 2002. 76: 8050-8057.